Immediate Impact
18 from Science/Nature 64 standout
Citing Papers
Cutaneous melanoma
2023 Standout
Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma
2023 Standout
Works of Matthew Squires being referenced
Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma
2014
Final results of a multicenter, open-label phase II trial of dovitinib (TKI258) in patients with advanced urothelial carcinoma with either mutated or nonmutated FGFR3.
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Matthew Squires | 1120 | 818 | 409 | 71 | 1.9k | |
| Mathias Schmidt | 1245 | 1046 | 274 | 58 | 2.2k | |
| Donna Headlee | 1445 | 1065 | 545 | 34 | 2.6k | |
| Jung-Sik Kim | 1499 | 588 | 307 | 45 | 2.2k | |
| Ramasamy Jagadeeswaran | 1118 | 593 | 726 | 46 | 2.2k | |
| Christine Fritsch | 1773 | 595 | 392 | 38 | 2.5k | |
| Sabina Cosulich | 1928 | 512 | 279 | 55 | 2.6k | |
| Babita Madan | 1629 | 728 | 151 | 50 | 2.4k | |
| Juan Carlos Montero | 1688 | 1117 | 228 | 88 | 2.7k | |
| Maria Luisa Veronese | 956 | 672 | 334 | 35 | 1.8k | |
| Yuichi Ishikawa | 1314 | 460 | 454 | 109 | 2.4k |
All Works
Loading papers...